Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in Seven Clinical Trials

JACC This Week
04/12/2023 9 min
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in Seven Clinical Trials

Listen "Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in Seven Clinical Trials"

Descargar episodio Ver en sitio original

Episode Synopsis

Commentary by Dr. Valentin Fuster

More episodes of the podcast JACC This Week

Computable Quality, Community Screening, and TAVR Debate | JACC This Week 29/09/2025
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week 15/09/2025
Reframing Cardiovascular Care | JACC This Week 08/09/2025
Heart Failure Insights, AI Standards, and Genetic Clues | JACC This Week 03/09/2025
Cognitive Risk in CHD and Cardiology Practice Meets Lifestyle Realities | JACC This Week 25/08/2025
Pacing Strategies, Air Quality, and the Path to Equity | JACC This Week 18/08/2025
Device Safety, DAPT Strategy & Structural Innovation | JACC This Week 11/08/2025
Amyloidosis in Focus: Biomarkers, Structural Insights & Therapeutic Strategy | JACC This Week 04/08/2025
Out-of-Hospital Cardiac Arrest in Septuagenarians, Octogenarians, and Nonagenarians in Japan: Trends and Patterns in Outcomes | JACC Baran 29/07/2025
Zeroing In on Prevention: ARIC and the Future of Cardiovascular Risk | JACC Baran 29/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA